These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9424064)

  • 1. Early behavior of biochemical markers in patients with thrombolysis in myocardial infarction grade 2 flow in the infarct artery as opposed to other flow grades after intravenous thrombolysis for acute myocardial infarction. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Laperche T; Golmard JL; Steg PG
    Am Heart J; 1997 Dec; 134(6):1044-51. PubMed ID: 9424064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Laperche T; Steg PG; Dehoux M; Benessiano J; Grollier G; Aliot E; Mossard JM; Aubry P; Coisne D; Hanssen M
    Circulation; 1995 Oct; 92(8):2079-86. PubMed ID: 7554185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
    Tanasijevic MJ; Cannon CP; Antman EM; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Braunwald E
    J Am Coll Cardiol; 1999 Sep; 34(3):739-47. PubMed ID: 10483955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
    Tanasijevic MJ; Cannon CP; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Antman EM; Braunwald E
    Am Heart J; 1997 Oct; 134(4):622-30. PubMed ID: 9351728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.
    Christenson RH; Ohman EM; Topol EJ; Peck S; Newby LK; Duh SH; Kereiakes DJ; Worley SJ; Alosozana GL; Wall TC; Califf RM
    Circulation; 1997 Sep; 96(6):1776-82. PubMed ID: 9323061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
    de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
    Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion.
    Laperche T; Steg PG; Benessiano J; Dehoux M; Juliard JM; Himbert D; Gourgon R
    Am J Cardiol; 1992 Nov; 70(13):1129-34. PubMed ID: 1414933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.
    Stewart JT; French JK; Théroux P; Ramanathan K; Solymoss BC; Johnson R; White HD
    J Am Coll Cardiol; 1998 Jun; 31(7):1499-505. PubMed ID: 9626826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis.
    Zabel M; Hohnloser SH; Köster W; Prinz M; Kasper W; Just H
    Circulation; 1993 May; 87(5):1542-50. PubMed ID: 8491009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the Thrombolysis in Myocardial Infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction.
    Fath-Ordoubadi F; Huehns TY; Al-Mohammad A; Beatt KJ
    Am Heart J; 1997 Jul; 134(1):62-8. PubMed ID: 9266784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.
    Anderson JL; Karagounis LA; Becker LC; Sorensen SG; Menlove RL
    Circulation; 1993 Jun; 87(6):1829-39. PubMed ID: 8504495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
    de Lemos JA; Antman EM; Morrow DA; Llevadot J; Giugliano RP; Coulter SA; Schuhwerk KC; Arslanian S; McCabe CH; Gibson CM; Rifai N
    Clin Chim Acta; 2000 Aug; 298(1-2):85-97. PubMed ID: 10876006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
    Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
    J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
    Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
    Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trial.
    Gibson CM; Marble SJ; Rizzo MJ; Moynihan J; McLean C; Ryan K; Sparano A; Piana RN; McCabe C; Cannon CP
    Am Heart J; 1997 Sep; 134(3):351-4. PubMed ID: 9327688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies.
    Vogt A; von Essen R; Tebbe U; Feuerer W; Appel KF; Neuhaus KL
    J Am Coll Cardiol; 1993 May; 21(6):1391-5. PubMed ID: 8473646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.